Molecular etiopathogenesis of spinal muscular atrophy

被引:0
|
作者
Tomek, A [1 ]
Matoska, V [1 ]
Goetz, P [1 ]
Hedvicáková, P [1 ]
Bauer, P [1 ]
Bóday, A [1 ]
机构
[1] LF UK FN Motol, Neurol Klin 2, Prague 15000 5, Czech Republic
关键词
ethiopathogenesis; spinal muscular atrophy;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Spinal muscular atrophy (SMA) is an autosomal recesive hereditary disease caused by premature atrophy of motor neurons of the anterior spinal horns. With regard to the severity of the disease three types of SMA are described: SMA I, II, III. SMA is caused by mutations by the gene Survival Motor Neuron I (SMNI). Gene SMNI is on chromosome 5q13, which contains many repetitive sequences and pseudogenes. Among the pseudogenes is also gene SMN2 which differs from gene SMNI only in 6 nucleotides. The product of gene SMN1, and to a smaller extent SMN2, is protein SMN which participates in the posttranscription metabolism of mRNA of all cell types and in a not too well known way also in the metabolism of the alpha-motor neurons of the anterior spinal horns. Protein SMN has several splicing isoforms. 90% of all transcripts of the SMN1 gene is complete and fully functional. They have all 7 exons. An opposite situation is found in transcription of gene SMN2 where only 10-30% transcripts are fully functional, it contains all 7 exons. The severity of the disease depends on the presence of the amount of functional molecules of protein SMN. The most frequent mutation are deletions comprising in 93% patients exon 7 and 8 of gene SMN1. In 3-6% patients an isolated deletion of exon 7 is involved. Less frequent are point mutations (1-2 patients with SM I, 4-5% patients with SMA II and III); so far some 20 patients were identified and 20 different point mutations. Another mechanism of development of mutations in gene SMN1 is gene conversion of gene SMN1 to gene SMN2. This mechanism explains also the increase of the number of copies of SMN2.
引用
收藏
页码:313 / 320
页数:8
相关论文
共 50 条
  • [21] Molecular studies of infant spinal muscular atrophy in Cuba
    Montejo, Y
    Acevedo, AM
    Zaldivar, T
    Guerra, R
    [J]. ANNALS OF NEUROLOGY, 2004, 56 : S29 - S29
  • [22] Molecular Biomarkers for Spinal Muscular Atrophy A Systematic Review
    Navarrete-Opazo, Angela
    Garrison, Sheldon
    Waite, Mindy
    [J]. NEUROLOGY-CLINICAL PRACTICE, 2021, 11 (04) : E524 - E536
  • [23] Clinical and molecular diagnosis of spinal muscular atrophy in Moldova
    Ciumas, M.
    Sacara, V.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 : 159 - 160
  • [24] Molecular mechanisms and animal models of spinal muscular atrophy
    Edens, Brittany M.
    Ajroud-Driss, Senda
    Ma, Long
    Ma, Yong-Chao
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2015, 1852 (04): : 685 - 692
  • [25] Spinal muscular atrophy
    Talbot, K
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 1999, 22 (04) : 545 - 554
  • [26] Spinal muscular atrophy
    Chokri, M.
    Salma, S.
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [27] Spinal Muscular Atrophy
    Nicolau, Stefan
    Waldrop, Megan A.
    Connolly, Anne M.
    Mendell, Jerry R.
    [J]. SEMINARS IN PEDIATRIC NEUROLOGY, 2021, 37
  • [28] Spinal muscular atrophy
    Martin, Pascal
    Horber, Veronka
    Park, Joohyun
    Kronlage, Cornelius
    Grimm, Alexander
    [J]. NERVENARZT, 2022, 93 (02): : 191 - 200
  • [29] Spinal muscular atrophy
    Lunn, Mitchell R.
    Wang, Ching H.
    [J]. LANCET, 2008, 371 (9630): : 2120 - 2133
  • [30] Spinal muscular atrophy
    Mercuri, Eugenio
    Sumner, Charlotte J.
    Muntoni, Francesco
    Darras, Basil T.
    Finkel, Richard S.
    [J]. NATURE REVIEWS DISEASE PRIMERS, 2022, 8 (01)